Notch1 is associated with the multidrug resistance of hypoxic osteosarcoma by regulating MRP1 gene expression

Neoplasma
|July 30, 2016
PubMed

Insights

Hypoxia enhances osteosarcoma cell growth and drug resistance by upregulating Notch1 signaling. Inhibiting Notch1 with siRNA reduces proliferation and sensitizes cells to chemotherapy by downregulating multidrug resistance protein-1 (MRP1).

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Hypoxia and Notch signaling are implicated in tumor progression and drug resistance.
  • The specific roles of hypoxia and Notch signaling in osteosarcoma (OS) cell proliferation and drug resistance require further elucidation.

Purpose of the Study:

  • To investigate the molecular mechanisms of hypoxia and Notch1 signaling in osteosarcoma cell proliferation and drug resistance.
  • To evaluate the effect of inhibiting the Notch1 pathway using Notch1 small interference RNA (siRNA) on human MG-63 OS cells under hypoxic conditions.

Main Methods:

  • Culturing human MG-63 osteosarcoma cells under hypoxic conditions.
  • Utilizing Notch1 siRNA to inhibit the Notch1 signaling pathway.
  • Assessing cell proliferation, apoptosis, cell cycle, and expression of HIF-1α, Notch1, and multidrug resistance protein-1 (MRP1) via Western blot analysis.

Main Results:

  • Hypoxia promoted osteosarcoma cell proliferation, induced cell cycle transition (G0/G1-S-G2/M), and increased multidrug resistance.
  • Hypoxia led to increased expression of HIF-1α, Notch1, and MRP1 in osteosarcoma cells.
  • Notch1 siRNA significantly inhibited proliferation, enhanced apoptosis in hypoxic osteosarcoma cells, and sensitized them to multidrug treatment by downregulating MRP1.

Conclusions:

  • Notch signaling is upregulated in human osteosarcoma cells under hypoxia.
  • Notch1 inhibition represents a potential therapeutic strategy to overcome chemoresistance in hypoxic osteosarcoma by regulating MRP1 gene expression.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.8K
Notch Signaling Pathway03:14

Notch Signaling Pathway

6.4K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.6K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K